Mirae Asset Global Investments
XPH icon

Mirae Asset Global Investments’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Mirae Asset Global Investments’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-24,900
Closed -$1.1M – 564
2016
Q3 		$1.1M Sell
24,900
-9,700
-28% -$440K 0.02% 335
2016
Q2 		$1.45M Buy
+34,600
New +$1.47M 0.04% 266

Other funds holding XPH

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

Mirae Asset Global Investments's XPH Position: Q4 2016 in Review

Mirae Asset Global Investments sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2016, closing a stake of 24,900 shares — an estimated $1.1M sold.

Mirae Asset Global Investments first reported a position in XPH in Q2 2016 and held it in 2 quarters. The position peaked at $1.45M in Q2 2016. 78 funds tracked by Wall St. Rank hold XPH as of Q4 2016.

  • Mirae Asset Global Investments reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2016 after selling out during the quarter.
  • Mirae Asset Global Investments sold 24,900 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2016, an estimated $1.1M.
  • Mirae Asset Global Investments first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2016 and held it in 2 quarters.
  • Mirae Asset Global Investments's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.45M in Q2 2016.
  • 78 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2016.

Based on Mirae Asset Global Investments's 13F filing for Q4 2016, filed 7 Feb 2017.